| Systematic (IUPAC) name | |
|---|---|
| 2-(2-ethyl-5-methoxy-1H-indol-3-yl)-N,N-dimethylethanamine | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| ATC code | None |
| PubChem | CID 6918513 |
| IUPHAR ligand | 12 |
| ChemSpider | 5293710 |
| Chemical data | |
| Formula | C15H22N2O |
| Mol. mass | 246.347 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
2-Ethyl-5-methoxy-N,N-dimethyltryptamine (EMDT) is a tryptamine derivative which is used in scientific research. It acts as a selective 5-HT6 receptor agonist, with a Ki of 16 nM, and was one of the first selective agonists developed for this receptor.[1] EMDT inhibits both short- and long-term memory formation in animal studies, and this effect can be reversed by the selective 5-HT6 antagonist SB-399,885.[2] Additionally, it is active in the tail suspension test, suggesting that it could be an effective antidepressant.[3]
|
|||||
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)